Jefferies Financial Group’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2K Sell
10,000
-5,972
-37% -$7.32K ﹤0.01% 1259
2026
Q2
$19.6K Buy
15,972
+5,972
+60% +$5.95K ﹤0.01% 1601
2026
Q1
$7.02K Hold
10,000
– – ﹤0.01% 1689
2025
Q4
$15.5K Buy
+10,000
New +$16K ﹤0.01% 1809

Other funds holding MXCT

Jefferies Financial Group's MXCT Position: Q3 2026 in Review

Jefferies Financial Group reduced its MaxCyte (MXCT) stake by 37% in Q3 2026, selling an estimated $7.32K and leaving 10,000 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Jefferies Financial Group first reported a position in MXCT in Q4 2025 and has held it in 4 quarters since. The position peaked at $19.6K in Q2 2026. 81 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Jefferies Financial Group held 10,000 shares of MaxCyte worth $11.2K as of Q3 2026.
  • Jefferies Financial Group sold 5,972 MaxCyte shares in Q3 2026, an estimated $7.32K.
  • MaxCyte made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1259 holding.
  • Jefferies Financial Group first reported a position in MaxCyte in Q4 2025 and has held it in 4 quarters since.
  • Jefferies Financial Group's MaxCyte position peaked at $19.6K in Q2 2026.
  • 81 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.